Genetic influence on bloodstream infections and sepsis

International Journal of Antimicrobial Agents

Volumn 32, Issue SUPPL. 1, 2008, Pages

  Kumpf, Oliver ^a   Schumann, Ralf R ^b  

^a Section of Pathology   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bloodstream infection; Cytokines; Genetic predisposition; Sepsis; Single nucleotide polymorphism SNP; Toll like receptors TLRs

Indexed keywords

CD14 ANTIGEN; CYTOKINE; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE BINDING PROTEIN; MANNOSE BINDING LECTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOODSTREAM INFECTION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; INFECTION; INNATE IMMUNITY; MOLECULAR RECOGNITION; PRIORITY JOURNAL; SEPSIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

CYTOKINES; DISEASE SUSCEPTIBILITY; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC; SEPSIS;

EID: 53849123969     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.08.002     Document Type: Article

References (75)

1. Thomson G., and Esposito M.S. The genetics of complex diseases. Trends Cell Biol 9 (1999) M17-20
2. Sorensen T.I., Nielsen G.G., Andersen P.K., and Teasdale T.W. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 318 (1988) 727-732
3. International HapMap Consortium. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
4. Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22 (1999) 231-238
5. Rebbeck T.R., Spitz M., and Wu X. Assessing the function of genetic variants in candidate gene association studies. Nat Rev Genet 5 (2004) 589-597
6. March R.E. Gene mapping by linkage and association analysis. Mol Biotechnol 13 (1999) 113-122
7. Zhang D.X., and Hewitt G.M. Nuclear DNA analyses in genetic studies of populations: practice, problems and prospects. Mol Ecol 12 (2003) 563-584
8. Moine P., and Abraham E. Immunomodulation and sepsis: impact of the pathogen. Shock 22 (2004) 297-308
9. O'Grady N.P., Alexander M., Dellinger E.P., Gerberding J.L., Heard S.O., Maki D.G., et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 51 (2002) 1-29
10. Raad I., Hanna H., and Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 7 (2007) 645-657
11. Taylor G., Buchanan-Chell M., Kirkland T., McKenzie M., and Wiens R. Long term trends in the occurrence of nosocomial blood stream infection. Can J Infect Dis 11 (2000) 29-33
12. Remick D.G. Pathophysiology of sepsis. Am J Pathol 170 (2007) 1435-1444
13. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
14. Sriskandan S., and Altmann D.M. The immunology of sepsis. J Pathol 214 (2008) 211-223
15. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al., SCCM/ESICM/ACCP/ATS/SIS, 2001. SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit. Care Med. 2003; 31: 1250-6.
16. Volk H.D., Reinke P., and Döcke W.D. Clinical aspects: from systemic inflammation to 'immunoparalysis'. Chem Immunol 74 (2000) 162-177
17. Kesh S., Mensah N.Y., Peterlongo P., Jaffe P., Hsu K., van den Brink M., et al. TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Ann NY Acad Sci 1062 (2005) 95-103
18. Hawn T.R., Misch E.A., Dunstan S.J., Thwaites G.E., Lan N.T., Quy H.T., et al. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol 37 (2007) 2280-2289
19. Sutherland A.M., Walley K.R., and Russell J.A. Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med 33 (2005) 638-644
20. Lorenz E., Mira J.P., Cornish K.L., Arbour N.C., and Schwartz D.A. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 68 (2000) 6398-6401
21. Moore C.E., Segal S., Berendt A.R., Hill A.V., and Day N.P. Lack of association between Toll-like receptor 2 polymorphisms and susceptibility to severe disease caused by Staphylococcus aureus. Clin Diagn Lab Immunol 11 (2004) 1194-1197
22. Feterowski C., Emmanuilidis K., Miethke T., Gerauer K., Rump M., Ulm K., et al. Effects of functional Toll-like receptor-4 mutations on the immune response to human and experimental sepsis. Immunology 109 (2003) 426-431
23. Jessen K.M., Lindboe S.B., Petersen A.L., Eugen-Olsen J., Benfield T., and Common TNF-alpha. IL-1 beta, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis. BMC Infect Dis 7 (2007) 108
24. Agnese D.M., Calvano J.E., Hahm S.J., Coyle S.M., Corbett S.A., Calvano S.E., et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 186 (2002) 1522-1525
25. Hubacek J.A., Stüber F., Fröhlich D., Book M., Wetegrove S., Ritter M., et al. Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis. Crit Care Med 29 (2001) 557-561
26. Chien J.W., Boeckh M.J., Hansen J.A., and Clark J.G. Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantation. Blood 111 (2008) 2462-2469
27. Hamann L., Kumpf O., Müller M., Visintin A., Eckert J., Schlag P.M., et al. A coding mutation within the first exon of the human MD-2 gene results in decreased lipopolysaccharide-induced signaling. Genes Immun 5 (2004) 283-288
28. Medvedev A.E., Lentschat A., Kuhns D.B., Jorge C.G., Salkowski B.C., Zhang S., et al. Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J Exp Med 198 (2003) 521-531
29. Arcaroli J., Silva E., Maloney J.P., He Q., Svetkauskaite D., Murphy J.R., et al. Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis. Am J Respir Crit Care Med 173 (2006) 1335-1341
30. Khor C.C., Chapman S.J., Vannberg F.O., Jaffe D., Hsu K., Van den Brink M., et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 39 (2007) 523-528
31. Chapman S.J., Khor C.C., Vannberg F.O., Frodsham A., Walley A., Maskell N.A., et al. IkappaB genetic polymorphisms and invasive pneumococcal disease. Am J Respir Crit Care Med 176 (2007) 181-187
32. Mira J.P., Cariou A., Grall F., Delclaux C., Losser M.R., Heshmeri F., et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282 (1999) 561-568
33. Waterer G.W., Quasney M.W., Cantor R.M., and Wunderink R.G. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am J Respir Crit Care Med 163 (2001) 1599-1604
34. Tang G.J., Huang S.L., Yien H.W., Chen W.S., Chi C.W., Wu C.W., et al. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 28 (2000) 2733-2736
35. Gordon A.C., Lagan A.L., Aganna E., Cheung L., Peters C.J., McDermott M.F., et al. TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study. Genes Immun 5 (2004) 631-640
36. Ma P., Chen D., Pan J., and Du B. Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients. Crit Care Med 30 (2002) 1046-1050
37. Read R.C., Camp N.J., di Giovine F.S., Borrow R., Kaczmarski B., Chaudhary A.G., et al. An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. J Infect Dis 182 (2000) 1557-1560
38. Schluter B., Raufhake C., Erren M., Schotte H., Kipp F., Rust S., et al. Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med 30 (2002) 32-37
39. Tischendorf J.J., Yagmur E., Scholten D., Vidacek D., Koch A., Winograd A.M., et al. The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6. Int J Immunogenet 34 (2007) 413-418
40. Zhu X.L., Du T., Li J.H., Lu L.P., Guo X.H., Gao J.R., et al. Association of HLA-DQB1 gene polymorphisms with outcomes of HBV infection in Chinese Han population. Swiss Med Wkly 137 (2007) 114-120
41. Stassen N.A., Leslie-Norfleet L.A., Robertson A.M., Eichenberger M.R., and Polk Jr. H.C. Interferon-gamma gene polymorphisms and the development of sepsis in patients with trauma. Surgery 132 (2002) 289-292
42. Shu Q., Fang X., Chen Q., and Stüber F. IL-10 polymorphism is associated with increased incidence of severe sepsis. Chin Med J (Engl) 116 (2003) 1756-1759
43. Gallagher P.M., Lowe G., Fitzgerald T., Bella A., Greene C.M., McElvancy N.G., et al. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 58 (2003) 154-156
44. Arnalich F., Lopez-Maderuelo D., Codoceo R., Lopez J., Solis-Garrido L.M., Capiscol C., et al. Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis. Clin Exp Immunol 127 (2002) 331-336
45. Adewoye A.H., Nolan V.G., Ma Q., Baldwin C., Wyszynski J.J., Farrell L.A., et al. Association of polymorphisms of IGF1R and genes in the transforming growth factor-beta/bone morphogenetic protein pathway with bacteremia in sickle cell anemia. Clin Infect Dis 43 (2006) 593-598
46. Westendorp R.G., Hottenga J.J., and Slagboom P.E. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock. Lancet 354 (1999) 561-563
47. Kremer Hovinga J.A., Franco R.F., Zago M.A., Ten Cate H., Westendorp R.G., and Reitsma P.H. A functional single nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal disease. J Thromb Haemost 2 (2004) 54-57
48. Yan S.B., and Nelson D.R. Effect of factor V Leiden polymorphism in severe sepsis and on treatment with recombinant human activated protein C. Crit Care Med 32 Suppl. 5 (2004) S239-S246
49. Manocha S., Russell J.A., Sutherland A.M., Wattanathum A., and Walley K.R. Fibrinogen-beta gene haplotype is associated with mortality in sepsis. J Infect 54 (2007) 572-577
50. Domingo P., Muniz-Diaz E., Baraldes M.A., Arilla M., Barquet N., Pericas R., et al. Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease. Am J Med 112 (2002) 19-25
51. Villar J., Flores C., Perez-Mendez L., Maca-Meyer N., Espinosa E., Blanco J., et al. Angiotensin-converting enzyme insertion/deletion polymorphism is not associated with susceptibility and outcome in sepsis and acute respiratory distress syndrome. Intensive Care Med 34 (2008) 488-495
52. Saleh M., Vaillancourt J.P., Graham R.K., Huyck M., Srinivascula S.M., Al-nemri E.S., et al. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 429 (2004) 75-79
53. Bredius R.G., Derkx B.H., Fijen C.A., de Wit T.P., de Hass M., Weening R.S., et al. Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 170 (1994) 848-853
54. Chapman S.J., Vannberg F.O., Khor C.C., Segal S., Moore C.E., Knox K., et al. Functional polymorphisms in the FCN2 gene are not associated with invasive pneumococcal disease. Mol Immunol 44 (2007) 3267-3270
55. Schroder O., Schulte K.M., Ostermann P., Roher H.D., Ekkernkamp A., and Laun R.A. Heat shock protein 70 genotypes HSPA1B and HSPA1L influence cytokine concentrations and interfere with outcome after major injury. Crit Care Med 31 (2003) 73-79
56. Neth O., Hann I., Turner M.W., and Klein N.J. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 358 (2001) 614-618
57. Villullas S., Hill D.J., Sessions R.B., Rea J., and Virji M. Mutational analysis of human CEACAM1: the potential of receptor polymorphism in increasing host susceptibility to bacterial infection. Cell Microbiol 9 (2007) 329-346
58. Beutler B. Innate immunity: an overview. Mol Immunol 40 (2004) 845-859
59. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 449 (2007) 819-826
60. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
61. Schröder N.W.J., and Schumann R.R. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis 5 (2005) 156-164
62. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25 (2000) 187-191
63. Lorenz E., Mira J.P., Frees K.L., and Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 162 (2002) 1028-1032
64. Kumpf O., Hamann L., Schlag P.M., and Schumann R.R. Pre- and postoperative cytokine release after in vitro whole blood lipopolysaccharide stimulation and frequent toll-like receptor 4 polymorphisms. Shock 25 (2006) 123-128
65. von Aulock S., Schröder N.W.J., Gueinzius K., Traub S., Hoffmann S., Graf K., et al. Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood. J Infect Dis 188 (2003) 938-943
66. Van der Graaf C.A., Netea M.G., Morre S.A., Den Heijer M., Verweij P.E., Van der Meer J.W., et al. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur Cytokine Netw 17 (2006) 29-34
67. Gibot S., Cariou A., Drouet L., Rossignol M., and Ripoll L. Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med 30 (2002) 969-973
68. Stüber F., Petersen M., Bokelmann F., and Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 24 (1996) 381-384
69. Sutherland A.M., Walley K.R., Manocha S., and Russell J.A. The association of interleukin 6 haplotype clades with mortality in critically ill adults. Arch Intern Med 165 (2005) 75-82
70. Gao L., Flores C., Fan-Ma S., Miller E.J., Moitra L., Moreno L., et al. Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations. Transl Res 150 (2007) 18-29
71. Hofner P., Gyulai Z., Kiss Z.F., Tiszai A., Tiszlavicz G., Toth G., et al. Genetic polymorphisms of NOD1 and IL-8, but not polymorphisms of TLR4 genes, are associated with Helicobacter pylori-induced duodenal ulcer and gastritis. Helicobacter 12 (2007) 124-131
72. Opal S.M., and DePalo V.A. Anti-inflammatory cytokines. Chest 117 (2000) 1162-1172
73. Shu Q., Shi C.C., Zhang X.H., Shi Z., Shi S.S., Fang X.M., et al. Interleukin 10, G microsatellite in the promoter region of the interleukin-10 gene in severe sepsis. Chin Med J (Engl) 119 (2006) 197-201
74. van Sorge N.M., van der Pol W.L., and van de Winkel J.G. FcgammaR polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens 61 (2003) 189-202
75. Mullighan C.G., and Bardy P.G. Mannose-binding lectin and infection following allogeneic hemopoietic stem cell transplantation. Leuk Lymphoma 45 (2004) 247-256